Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 41,630 | 47,397 | 46,850 | 56,558 | 69,025 |
| Cost of Goods | 35,975 | 39,629 | 39,125 | 37,168 | 36,791 |
| Gross Profit | 5,655 | 7,768 | 7,725 | 19,390 | 32,234 |
| Operating Expenses | 47,661 | 74,675 | 57,012 | 57,260 | 198,639 |
| Operating Income | -41,031 | -66,278 | -49,162 | -37,702 | -165,614 |
| Interest Expense | 6,844 | 6,815 | 6,778 | 11,263 | 13,634 |
| Other Income | 2,726 | -1,032 | 3,249 | 2,891 | 7,104 |
| Pre-tax Income | -45,149 | -74,125 | -52,691 | -46,074 | -172,144 |
| Income Tax | -92 | -4,288 | 162 | -7 | 311 |
| Net Income Continuous | -45,057 | -69,837 | -52,853 | -46,067 | -172,455 |
| Minority Interests | -19,501 | -30,246 | -22,908 | -20,162 | -75,381 |
| Net Income | $-25,556 | $-39,591 | $-29,945 | $-25,905 | $-97,074 |
| EPS Basic Total Ops | -0.18 | -0.27 | -0.21 | -0.21 | -0.68 |
| EPS Basic Continuous Ops | -0.31 | -0.48 | -0.37 | -0.36 | -1.22 |
| EPS Diluted Total Ops | -0.18 | -0.27 | -0.21 | -0.21 | -0.68 |
| EPS Diluted Continuous Ops | -0.31 | -0.48 | -0.37 | -0.36 | -1.22 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.12 | -0.15 | -0.14 | -0.09 |
| EBITDA(a) | $-25,189 | $-20,052 | $-21,356 | $-10,606 | $3,418 |